Skip to content

Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery

Utilizing Photobiomodulation Via Laser Diode Belts To Treat Chronic Lower Back Pain in Patients Who Have Undergone Spinal Fusion and Decompression Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06282770
Enrollment
80
Registered
2024-02-28
Start date
2023-07-01
Completion date
2026-07-01
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lower Back Pain, Spinal Fusion

Keywords

Photobiomodulation, Laser Diode, Inflammation, Spinal Fusion, Spinal Decompression, Lumbar, Back Pain

Brief summary

After spinal fusion and decompression surgery there is a possible risk of developing chronic back pain. After surgery there is typically inflammation around the operation site and this inflammation can be painful and debilitating to patients. Many possible treatment plans have been incorporated to assist the patient with recovery - notably medications, physical therapy, and braces. However, few studies have looked at laser diodes that utilize high-power laser lights that are aimed at decreasing pain and inflammation. Investigators aim to look compare patients using a back brace with laser diodes within versus those who wear a normal brace used as a placebo. Investigators will also assess the patient's surgical wound to monitor the progression of wound healing while using the brace.

Detailed description

This study will review charts of 80 patients who have experienced chronic back pain at various operative sites of a teaching medical institution, including the inpatient academic medical center, outpatient ambulatory hospital, and regional trauma center. Deidentified demographic data that will be collected via extensive chart reviews include age, sex, BMI, preoperative diagnosis, pre- and post-operative pain scales, motor exams, and function questionnaires. Operative data will include operative time and estimated blood loss (EBL). Patients that have already expressed interest in receiving spinal fusion or decompression surgery will come into clinic for consultation and enrollment in the study. Regardless of study participation, patients will receive either surgery. For the study, 80 subjects will be enrolled (40 with minimally invasive spinal fusion and 40 with minimally invasive decompression surgeries). Prior to the surgery date, subjects will complete pre-operation questionnaires that include the Visual Analogue Scale (VAS) and the Oswestry-Low-Back-Pain-Disability Index (ODI) to self-evaluate their current pain level and ability to perform basic lifestyle functions, respectively. Following surgery, enrolled subjects will then receive a brace that contains laser diodes or a sham (placebo) brace that appears identical to the diode-containing brace but lacks functional diodes. Subjects will wear the brace 3 times/day for 12 minutes each session for 12 weeks. They will complete and submit via the REDCap electronic submission portal the VAS and ODI questionnaires at the following time points after surgery: 2, 4, 6, 8, and 12 weeks. Subjects will also submit photos of their surgical scars for evaluation by the research study team members. Scar and wound healing will be assessed using image analysis software (Image J) according to the Stony Brook Scar Evaluation scale. Photos will be stored on a safe and secure encrypted server.

Interventions

DEVICELaser Diode Brace

The device is a brace with laser diodes. The braces light up and the red light has therapeutic abilities.

DEVICESham Laser Diode Brace

The Sham brace has no therapeutic ability and will act as a placebo.

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Participants in this study will not be told which belt is the sham diode brace or which is the functional diode brace. The assessor of the study will also be blinded to which belt each subject has, and data will be analyzed blindly based on patient ID alone.

Intervention model description

Participants are assigned in parallel to one of two arms (active photobiomodulation brace or sham brace). Assignment occurs once prior to surgery and remains fixed for the duration of the 12-week study. There is no crossover between arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Subject will have undergone minimally invasive spinal fusion surgery or spinal decompression surgery in their lower back L1-S1. * Have low back pain of \>3 months and a pain threshold of \> 4 (as described by the the subject), age \> 18 years, and English speaking to eliminate possible miscommunication and consequent human error regarding belt use. * Subject must have had surgery at minimum to 1 year prior to start of study and no more than 5 years prior to start to study

Exclusion criteria

* Patients with tumors * Current infection * Drug misuse history * Skin conditions preclude the use of laser belt * Severe spondylolisthesis, spondylolysis, spinal stenosis, ankylosing spondylitis * Previous low back surgery exceeding 5 years to initial start date.

Design outcomes

Primary

MeasureTime frameDescription
Self-reported patient outcome questionnaires after photobiomodulation therapy - VAS3 monthsSubjects will fill out two questionnaires related to their pain and quality of life before and after surgery with laser diode brace photobiomodulation therapy. The first survey is the Visual Analog Scale (VAS), which asks subjects to state how good or bad their current health state is on a scale of 0-100, 1 being the worst imaginable health state and 100 being the best imaginable health state. There are two additional questions that ask subjects to provide a rate their current back and leg pain on a scale of 0-10, with 0 being no pain and 10 being worst imaginable pain.
Self-reported patient outcome questionnaires after photobiomodulation therapy - ODI3 monthsThe second survey is the Oswestry Disability Index (ODI), which is designed to provide information on how the subject's pain is affecting their everyday life. There are 10 sections on the survey each graded on a scale from 0-5 with 5 being the most impaired. The total score scales from 0-50, where 0-10 denotes minimal disability and 40-50 denotes that the pain impinges on all aspects of their daily lives.

Secondary

MeasureTime frameDescription
Stony Brook Scar Evaluation3 monthsSurgical scar healing will be examined to see if there is any promotion of wound healing due to the therapeutic advantage from the brace photobiomodulation therapy. Assessments include scar/wound size (in mm) and scar/wound healing using the Image J software. The Stony Brook Scar Evaluation will score the scar from 0-5 where 5 shows significant healing.

Countries

United States

Contacts

Primary ContactDaniel Lu, Md, PhD
DCLu@mednet.ucla.edu310-267-2975
Backup ContactSandra Holley, PhD
sholley@mednet.ucla.edu3108252763

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026